Loading…
Tennant Company
🏹 Trader: 💎 VCP Breakout View all →
$1.2B
Market Cap
31.2
P/E
1.41
PEG
6.6%
ROCE
7.1%
ROE
0.51
D/E
5.7%
OPM
-22.7%
% from 52W High
23
α RS
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for TNC including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Tennant Company, together with its subsidiaries, designs, manufactures, and markets floor cleaning equipment in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
📊 MIXED Tennant reports Q1 2026 orders up 10% to $327M, AMR revenue up 85% to $27M; reaffirms FY guidance.
Revenue & Profitability
First-quarter 2026 net sales rose 2.7% year-over-year to $297.9M. GAAP net income was $0.2M, down from $13.1M a year ago. Adjusted diluted EPS was $0.58 versus $1.12. Adjusted EBITDA was $29.1M (9.8% margin) versus $41M (14.1%) in the prior year. The company reaffirmed full-year 2026 guidance: net sales $1.24B-$1.28B, adjusted EBITDA $175M-$190M, GAAP diluted EPS $4.05-$4.65, and adjusted diluted EPS $4.70-$5.30.
Outlook
Management sees robust demand momentum, with orders up 10% year-over-year to $327M and backlog building by $32M to $109M. The global robotic cleaning market is experiencing double-digit growth rates. The company expects results to be weighted to the second half of the year with sequential improvement each quarter. Full-year 2026 guidance was reaffirmed, reflecting confidence in underlying demand.
Growth Drivers
Key growth levers include the AMR and robotics business, which grew 85% year-over-year to $27M in Q1. New products such as the X16 SWEEP (industrial robotic sweeper) and X2 ROVR (small-format scrubber) expand the addressable market. International regions were strong: Latin America (up 9% organically), EMEA (up 1% organically with double-digit growth in France and Germany), and resilience in parts and consumables outside North America.
Balance Sheet & CapEx
Capital expenditure guidance for 2026 is approximately $25M. The company also invests around 3%-3.5% of sales in R&D. In Q1, Tennant deployed $60M to repurchase ~950,000 shares (5% of shares outstanding) at an average price of $63 per share, using borrowing capacity but remaining within its 1x-2x leverage target.
Margins
Q1 gross margin was 38.1%, down 330 basis points year-over-year, driven by ERP-related labor, freight, and expediting costs ($6M) and lost volume ($11M). Margins improved sequentially each month, exiting March at approximately 40%. Management expects gross margin to expand progressively, with second-half margins in the low-40% range, consistent with a long-term target of roughly 43%.
Key Risks
Key risks flagged include the ongoing impact of the North America ERP implementation, which reduced Q1 sales by ~$23M and gross margin by ~$17M. The company faces macro headwinds from tariffs (offset by pricing and cost-out actions) and potential freight cost increases due to the Middle East situation. The elevated Q1 effective tax rate (80.5%) due to discrete items is expected to normalize to 24%-29% for the full year.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-08-06
Q2 2026 saw strong demand and robotics growth, but profitability lagged due to ERP and cost pressures. Full-year sales guidance was raised, while EBITDA and EPS outlooks were lowered. Robotics is expected to accelerate in H2, with ERP normalization now targeted for H1 2027.
Q1 2026 Q1 2026 2026-05-05
Orders rose 10% year-over-year with strong robotics growth and a $32 million backlog increase. ERP recovery stabilized North America, but Q1 net income and margins declined due to disruption costs. Full-year guidance is reaffirmed, with margin expansion and robust capital allocation plans.
Q4 2025 Q4 2025 2026-02-24
Q4 and full year 2025 results were heavily impacted by a disruptive North America ERP go-live, causing significant sales and margin declines, though international growth and robotics momentum provided some offset. 2026 guidance anticipates recovery, margin expansion, and continued capital returns.
Q3 2025 Q3 2025 2025-11-04
Q3 2025 saw net sales of $303M with a 5.4% organic decline, but order growth continued and gross margin expanded. Tariff volatility and cost inflation pressured North America industrial demand, while new products and AMR robotics drove growth. Adjusted EBITDA margin improved 120 bps.
Q2 2025 Q2 2025 2025-08-07
Q2 2025 saw a 4.5% organic sales decline due to lapping a strong prior year, but order rates grew 4% and guidance was reaffirmed. Margin pressure from mix and tariffs is being offset by pricing and cost actions, with strong AMR and new product momentum supporting a positive second-half outlook.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.